UK consensus recommendations for clinical management of cancer risk for women with germline pathogenic variants in cancer predisposition genes: RAD51C, RAD51D, BRIP1 and PALB2

Hanson H., Kulkarni A., Loong L., Kavanaugh G., Torr B., Allen S., Ahmed M., Antoniou AC., Cleaver R., Dabir T., Evans DG., Golightly E., Jewell R., Kohut K., Manchanda R., Murray A., Murray J., Ong K-R., Rosenthal AN., Woodward ER., Eccles DM., Turnbull C., Tischkowitz M., Consensus meeting attendees F., Lalloo F.